Salivary Biomarkers Associated With Gingivitis and Response to Therapy

Abstract

Background Salivary biomarkers are potentially important for determining the presence, risk, and progression of periodontal disease. However, clinical translation of biomarker technology from lab to chairside requires studies that identify biomarkers associated with the transitional phase between health and periodontal disease (i.e., gingivitis). Methods Eighty participants (40 with gingivitis, 40 healthy) provided saliva at baseline and 7 to 30 days later. An additional sample was collected from gingivitis participants 10 to 30 days after dental prophylaxis. Clinical parameters of gingival disease were recorded at baseline and the final visit. Salivary concentrations of interleukin (IL)-1β, IL-6, matrix metalloproteinase (MMP)-8, macrophage inflammatory protein (MIP)-1α, and prostaglandin E2 (PGE2) were measured. Results Clinical features of health and gingivitis were stable at both baseline visits. Participants with gingivitis demonstrated significantly higher bleeding on probing (BOP), plaque index (PI), and gingival index (GI) (P ≤ 0.002) and a significant drop in BOP, PI, and GI post-treatment (P ≤ 0.001). Concentrations of MIP-1α and PGE2 were significantly higher (2.8 times) in the gingivitis group than the healthy group (P ≤ 0.02). After dental prophylaxis, mean biomarker concentrations did not decrease significantly from baseline in the gingivitis group, although concentrations of IL-1β, IL-6, and MMP-8 approached healthy levels, whereas MIP-1α and PGE2 concentrations remained significantly higher than in the healthy group (P ≤ 0.04). Odds ratio analyses showed that PGE2 concentrations, alone and in combination with MIP-1α, readily discriminated gingivitis from health. Conclusions Salivary PGE2 and MIP-1α discriminate gingivitis from health, and patients with gingivitis who return to clinical health continue to produce inflammatory mediators for weeks after dental prophylaxis.

Effects of bodybuilding and protein supplements in saliva, gingival crevicular fluid, and serum

“…A previous study detected IL-1β at extremely low concentrations in the serum of periodontally healthy patients and gingivitis patients (29). In addition, salivary IL-1β levels of gingivitis patients and healthy controls were reported to be similar (30). In accordance with the findings in the literature, in the present study, salivary levels of the evaluated genes were similar in groups G and H (Fig.…”

Serum and salivary cardiac analytes in acute myocardial infarction related to oral health status

“…While a limited number of analytes for both local and systemic diseases have been identified in saliva, biomarker discovery and validation depends upon an understanding of normal day-to-day variations 22,47 in a particular analyte, as well as identification of health states that would alter the analyte values. The current study evaluated key biomarkers of cardiovascular disease, including inflammation and myocardial damage in serum and saliva and documented effects of oral health/disease on the levels of these analytes in the fluids.…”

Regulation of inflammation by lipid mediators in oral diseases

“…Similarly, a different study found elevated levels of LTA 4 hydrolase in oral mucositis patients (Jehmlich et al , ). Elevated salivary levels of PGE2 were found to be correlated with gingivitis (Syndergaard et al , ; Gümüş et al , ) and periodontitis (Sánchez et al , ). In chronic periodontitis patients, salivary LTB 4 levels were to found to correlate with the severity of alveolar bone loss (Sánchez et al , ).…”